TXMD - TherapeuticsMD: Great Product But We Are Underwhelmed By Execution April, 21 2021 09:37 AM TherapeuticsMD Inc. TXMD has a market disruptive product called ANNOVERA. However, uptake has not been satisfactory. The company has high debt and needs to cut expenses. For further details see: TherapeuticsMD: Great Product, But We Are Underwhelmed By Execution